The OncAlert oral cancer product line from Vigilant Biosciences Inc., Fort Lauderdale, Fla, includes the OncAlert oral cancer rapid test and the OncAlert oral cancer lab test, available in countries accepting CE mark. The tests are based on technology that accurately measures CD44, a tumor-initiating and stem cell-associated biomarker, and total protein levels – markers clinically validated to be associated specifically with oral cancer. The tests are optimized for easy use by collecting samples via an oral saline rinse, and are performed via either point-of-care lateral flow assay or a laboratory kit.

Source: Clinical Lab Products